Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0CRBAW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CD79b-MMAE
|
|||||
| Synonyms |
CD79b-MMAE
Click to Show/Hide
|
|||||
| Organization |
Novartis Biomedical Research.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.8
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Site-specific bioconjugation via THIOMAB.
|
|||||
| Combination Type |
Vedotin
|
|||||